Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,844.40
(
-0.42%
)
Dow Jones
49,447.43
(
0.00%
)
Brent Oil
91.41
(
-1.34%
)
Bitcoin
75,467.54
(
2.17%
)
News Focus
News Focus
Post# of 257426
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biocqr

Send PM Follow Ignore
Followers 50
Posts 3530
Boards Moderated 0
Alias Born 08/24/2005

biocqr

Member Level

Re: DewDiligence post# 226421

Wednesday, 10/16/2019 10:32:23 AM

Wednesday, October 16, 2019 10:32:23 AM

Post# of 257426
ACHN > now trading @ 6.28 so the CVRs are basically free...

The transaction includes the potential for additional consideration in the form of non-tradeable contingent value rights (CVRs), which will be paid to Achillion shareholders if certain clinical and regulatory milestones are achieved within specified periods. These include $1.00 per share for the U.S. FDA approval of danicopan and $1.00 per share for ACH-5228 Phase 3 initiation.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today